You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech at (888) 835-2555.
ACTEMRA® (tocilizumab) is a prescription medicine used to treat:
ACTEMRA is not approved for subcutaneous use in people with SJIA or CRS.
It is not known if ACTEMRA is safe and effective in children with PJIA or SJIA under 2 years of age, in children with CRS under 2 years of age, or in children with conditions other than PJIA, SJIA or CRS.
ACTEMRA can cause serious side effects. ACTEMRA changes the way a patient’s immune system works. This can make a patient more likely to get infections or make any current infection worse. Some patients have serious infections while taking ACTEMRA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some patients taking ACTEMRA have died from these infections.
ACTEMRA can cause other serious side effects. These include:
ACTEMRA affects the immune system and may increase a patient’s risk of certain cancers.
Most common side effects in patients treated with ACTEMRA:
Patients must tell their doctor if they have these or any other side effect that bothers them or does not go away:
ACTEMRA & pregnancy:
Patients must tell their doctor if they are planning to become pregnant, are pregnant, plan to breast-feed, or are breast-feeding. The patient and their doctor should decide if the patient will take ACTEMRA or breast-feed. Patients should not do both. If a patient is pregnant and taking ACTEMRA, they must join the pregnancy registry. To learn more, patients should call 1-877-311-8972 or talk to their doctor to register.
Patients must tell their doctor right away if they are experiencing any side effects.
Report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Call Genentech at 1-888-835-2555.
Please see the full Prescribing Information, including BOXED WARNING and Medication Guide, for additional Important Safety Information.